Shuhuan Wu

Distribution and clinical correlates of viral and host genotypes in <scp>C</scp>hinese patients with chronic hepatitis <scp>C</scp> virus infection

Huiying Rao, Lai Wei, Juan Carlos López-Talavera et al. · Journal of Gastroenterology and Hepatology · 2013 · 122 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

A Randomized, Open-Label Clinical Study of Combined Pegylated Interferon Alfa-2a (40KD) and Entecavir Treatment for Hepatitis B "e" Antigen-Positive Chronic Hepatitis B

Qing Xie, Huijuan Zhou, Xue–Fan Bai et al. · Clinical Infectious Diseases · 2014 · 85 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Quantitative Hepatitis B Core Antibody Level Is a New Predictor for Treatment Response In HBeAg-positive Chronic Hepatitis B Patients Receiving Peginterferon

Feng-Qin Hou, Liuwei Song, Quan Yuan et al. · Theranostics · 2014 · 60 citations · Full text

Pharmacy, Immunology, Pharmacology +12

Hyaluronic acid&amp;ndash;nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo

You-Sin Jian, Ching‐Wen Chen, Chih-An Lin et al. · International Journal of Nanomedicine · 2017 · 52 citations · Full text

Pharmacy, Oncology, Pharmacology +15

RETRACTED: Overexpressed Tumor Suppressor Exosomal miR-15a-5p in Cancer Cells Inhibits PD1 Expression in CD8+T Cells and Suppresses the Hepatocellular Carcinoma Progression

Hongyu Zhang, Hongxia Liang, Shuhuan Wu et al. · Frontiers in Oncology · 2021 · 31 citations · Full text

Medicine, Molecular Biology, Oncology +17